Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium
Renato Polimanti, Raymond K. Walters, Emma C. Johnson, Jeanette N. McClintick, Amy E. Adkins, Daniel E. Adkins, Silviu-Alin Bacanu, Laura J. Bierut, Tim B. Bigdeli, Sandra Brown, Kathy Bucholz, William E. Copeland, E. Jane Costello, Louisa Degenhardt, Lindsay A Farrer, Tatiana M. Foroud, Louis Fox, Alison M. Goate, Richard Grucza, Laura M. Hack, Dana B. Hancock, Sarah M. Hartz, Andrew C. Heath, John K. Hewitt, Christian J. Hopfer, Eric O. Johnson, Kenneth S. Kendler, Henry R. Kranzler, Ken Krauter, Dongbing Lai, Pamela A. F. Madden, Nicholas G. Martin, Hermine H. Maes, Elliot C. Nelson, Roseann E. Peterson, Bernice Porjesz, Brien P. Riley, Nancy Saccone, Michael Stallings, Tamara Wall, Bradley T. Webb, Leah Wetherill the Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Howard J. Edenberg, Arpana Agrawal, Joel Gelernter
bioRxiv 765065; doi: https://doi.org/10.1101/765065